SYRE
Spyre Therapeutics Inc.
$47.58
$0.00(0.00%)
67
Overall
60
Value
75
Tech
--
Quality
Market Cap
$1.65B
Volume
438.07K
52W Range
$10.91 - $51.06
Target Price
$60.79
Key Metrics Overview
| Market Cap | $1.65B | P/E Ratio | N/A |
| 52W High | $51.06 | 52W Low | $10.91 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 0.0% | 52W Position | 91.3% |
| Overall Score | 67 | Value Score | 60 |
| Quality Score | -- | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-2.8 | EPS Next Est | $-2.77 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $47.58 | 0% | 438.07K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |